These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34990395)

  • 1. No association between breast pain and breast cancer: a prospective cohort study of 10 830 symptomatic women presenting to a breast cancer diagnostic clinic.
    Dave RV; Bromley H; Taxiarchi VP; Camacho E; Chatterjee S; Barnes N; Hutchison G; Bishop P; Hamilton W; Kirwan CC; Gandhi A
    Br J Gen Pract; 2022 Apr; 72(717):e234-e243. PubMed ID: 34990395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
    Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
    Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient management of new patient referrals to a breast service: the safe introduction of an advanced nurse practitioner-led telephone breast pain service.
    Ellis KS; Robinson CE; Foster R; Fatayer H; Gandhi A
    Ann R Coll Surg Engl; 2024 Apr; 106(4):359-363. PubMed ID: 37642083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis.
    Koo MM; von Wagner C; Abel GA; McPhail S; Rubin GP; Lyratzopoulos G
    Cancer Epidemiol; 2017 Jun; 48():140-146. PubMed ID: 28549339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
    Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L
    Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
    Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
    JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast clinic referrals: can mastalgia be managed in primary care?
    Joyce DP; Alamiri J; Lowery AJ; Downey E; Ahmed A; McLaughlin R; Hill AD
    Ir J Med Sci; 2014 Dec; 183(4):639-42. PubMed ID: 24402166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of breast reduction surgery for women with symptomatic breast hypertrophy.
    Crittenden TA; Ratcliffe J; Watson DI; Mpundu-Kaambwa C; Dean NR
    Med J Aust; 2022 Feb; 216(3):147-152. PubMed ID: 34784653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
    Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
    Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
    Connock M; Burls A; Frew E; Fry-Smith A; Juarez-Garcia A; McCabe C; Wailoo A; Abrams K; Cooper N; Sutton A; O'Hagan A; Moore D
    Health Technol Assess; 2006 Jul; 10(24):iii-iv, ix-136. PubMed ID: 16796930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT.
    Cooper K; Breeman S; Scott NW; Scotland G; Hernández R; Clark TJ; Hawe J; Hawthorn R; Phillips K; Wileman S; McCormack K; Norrie J; Bhattacharya S
    Health Technol Assess; 2019 Sep; 23(53):1-108. PubMed ID: 31577219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: mammography remains indicated.
    Noroozian M; Stein LF; Gaetke-Udager K; Helvie MA
    Breast Cancer Res Treat; 2015 Jan; 149(2):417-24. PubMed ID: 25556516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming the 2-week wait (2WW) pathway: management of breast pain in primary care.
    Jahan M; Bartholomeuz T; Milburn N; Rogers V; Sibbering M; Robertson J
    BMJ Open Qual; 2022 Mar; 11(1):. PubMed ID: 35289304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.
    Pataky R; Armstrong L; Chia S; Coldman AJ; Kim-Sing C; McGillivray B; Scott J; Wilson CM; Peacock S
    BMC Cancer; 2013 Jul; 13():339. PubMed ID: 23837641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of a low-fat diet in the prevention of breast and ovarian cancer.
    Bós AM; Howard BV; Beresford SA; Urban N; Tinker LF; Waters H; Bós AJ; Chlebowski R; Ennis JM
    J Am Diet Assoc; 2011 Jan; 111(1):56-66. PubMed ID: 21185966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of breast cancer in symptomatic women in primary care: a case-control study using electronic records.
    Walker S; Hyde C; Hamilton W
    Br J Gen Pract; 2014 Dec; 64(629):e788-93. PubMed ID: 25452544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of the NHS breast screening programme: life table model.
    Pharoah PD; Sewell B; Fitzsimmons D; Bennett HS; Pashayan N
    BMJ; 2013 May; 346():f2618. PubMed ID: 23661112
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.